bromocriptine has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liberante, FG; McMullin, MF; Mills, KI; Pouryahya, T; Zhang, SD | 1 |
| Banús-Mulet, A; Cornet-Masana, JM; Díaz-Beyá, M; Esteve, J; Etxabe, A; Lara-Castillo, MC; Nomdedeu, M; Risueño, RM; Torrente, MÁ | 1 |
2 other study(ies) available for bromocriptine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Bromocriptine; Case-Control Studies; Cell Proliferation; Dopamine Agonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Tumor Cells, Cultured | 2016 |
Repositioning of bromocriptine for treatment of acute myeloid leukemia.
Topics: Adult; Bromocriptine; CD11b Antigen; Cell Line, Tumor; Cell Survival; Drug Repositioning; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Young Adult | 2016 |